Skip to main content
Premium Trial:

Request an Annual Quote

Hoechst-Ariad Center Teams Up With Harvard, Licenses Pangea Tools

Premium

CAMBRIDGE, Mass.--The Hoechst-Ariad Genomics Center has signed an agreement with the Center for the Preven tion of Cardiovascular Disease of the Harvard School of Public Health to collaborate on the identification of novel genes involved in atherosclerosis and angiogenesis, and to license discoveries from the collaboration.

The center also recently licensed from Pangea Systems proprietary computational algorithms designed to feed accurate molecular information to the center's bioinformatics programs to increase the sensitivity with which molecular targets can be identified and the selectivity with which they can be validated for use in drug discovery. Pangea claimed that its clustering tools allow millions of expressed sequence tags to be rapidly analyzed with unprecedented precision.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.